These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [High-dose chemotherapy in relapse of medulloblastoma in young children]. Dupuis-Girod S; Hartmann O; Benhamou E; Doz F; Mechinaud F; Bouffet E; Coze C; Kalifa C Bull Cancer; 1997 Mar; 84(3):264-72. PubMed ID: 9207872 [TBL] [Abstract][Full Text] [Related]
26. Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience. Massimino M; Casanova M; Polastri D; Biassoni V; Modena P; Pecori E; Schiavello E; De Pava MV; Indini A; Rampini P; Bauer D; Catania S; Podda M; Gandola L Childs Nerv Syst; 2013 Jul; 29(7):1107-12. PubMed ID: 23595805 [TBL] [Abstract][Full Text] [Related]
27. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database. Brok J; Lopez-Yurda M; Tinteren HV; Treger TD; Furtwängler R; Graf N; Bergeron C; van den Heuvel-Eibrink MM; Pritchard-Jones K; Olsen ØE; de Camargo B; Verschuur A; Spreafico F Lancet Oncol; 2018 Aug; 19(8):1072-1081. PubMed ID: 29960848 [TBL] [Abstract][Full Text] [Related]
28. The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes. Hicks D; Rafiee G; Schwalbe EC; Howell CI; Lindsey JC; Hill RM; Smith AJ; Adidharma P; Steel C; Richardson S; Pease L; Danilenko M; Crosier S; Joshi A; Wharton SB; Jacques TS; Pizer B; Michalski A; Williamson D; Bailey S; Clifford SC Neuropathol Appl Neurobiol; 2021 Feb; 47(2):236-250. PubMed ID: 32779246 [TBL] [Abstract][Full Text] [Related]
29. Medulloblastoma--prognostic factors and outcome of treatment: review of the Mayo Clinic experience. Garton GR; Schomberg PJ; Scheithauer BW; Shaw EG; Ilstrup DM; Blackwell CR; Laws ER; Earle JD Mayo Clin Proc; 1990 Aug; 65(8):1077-86. PubMed ID: 2117687 [TBL] [Abstract][Full Text] [Related]
30. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725 [TBL] [Abstract][Full Text] [Related]
31. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. von Bueren AO; von Hoff K; Pietsch T; Gerber NU; Warmuth-Metz M; Deinlein F; Zwiener I; Faldum A; Fleischhack G; Benesch M; Krauss J; Kuehl J; Kortmann RD; Rutkowski S Neuro Oncol; 2011 Jun; 13(6):669-79. PubMed ID: 21636711 [TBL] [Abstract][Full Text] [Related]
32. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment. Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133 [TBL] [Abstract][Full Text] [Related]
33. Omission of Upfront Craniospinal Irradiation in Patients with Low-Risk WNT-Pathway Medulloblastoma Is Associated with Unacceptably High Risk of Neuraxial Failure. Gupta T; Pervez S; Dasgupta A; Chatterjee A; Epari S; Chinnaswamy G; Jalali R Clin Cancer Res; 2022 Oct; 28(19):4180-4185. PubMed ID: 35653134 [TBL] [Abstract][Full Text] [Related]
34. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy? Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932 [TBL] [Abstract][Full Text] [Related]
35. Local control in non-metastatic medulloblastoma. Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891 [TBL] [Abstract][Full Text] [Related]
36. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience. Atalar B; Ozsahin M; Call J; Napieralska A; Kamer S; Villa S; Erpolat P; Negretti L; Lassen-Ramshad Y; Onal C; Akyurek S; Ugurluer G; Baumert BG; Servagi-Vernat S; Miller RC; Ozyar E; Sio TT Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196 [TBL] [Abstract][Full Text] [Related]